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Background: The purpose of the study was to examine patients’ understanding of the revised screening
mammogram guidelines released by the United States Preventive Services Task Force (USPSTF) in 2009 addressing
age at initiation and frequency of screening mammography.
Methods: Patients from the Departments of Family Medicine, Internal Medicine, and Obstetrics and Gynecology
(n = 150) at a tertiary care medical center in the United States completed a survey regarding their understanding of
the revised USPSTF guidelines following their release, within four to six months of their scheduled mammogram
(March 2010 to May 2010).
Results: Of the patients surveyed, 97/147 (67%) indicated increased confusion regarding the age and frequency of
screening mammography, 61/148 (41%) reported increased anxiety about mammograms, and 58/146 (40%)
reported anxiety about their own health status following the release of the revised screening guidelines. Most of
the patients surveyed, 111/148 (75%), did not expect to change their timing or frequency of screening
mammograms in the future.
Conclusion: Results from this survey suggested increased confusion and possibly an increase in patients’ anxiety
related to screening mammography and their own health status following the release of the revised USPSTF
screening mammogram guidelines to the public and subsequent media portrayal of the revised guidelines.
Although the study did not specifically address causality for these findings, the results highlight the need for
improvements in the communication of guidelines to patients and the public. Development of shared
decision-making tools and outcomes should be considered to address the communication challenge.
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Breast cancer is the second most common cause of can-
cer mortality among women in the United States [1,2].
Screening mammography has been an important tool in
early detection of breast cancer, resulting in a decrease
in breast cancer mortality [3,4]. In November 2009, the
United States Preventive Services Task Force (USPSTF),
an independent panel of experts in prevention and
primary care, released a revision of the screening
mammogram guidelines pertaining to the age at which* Correspondence: pruthi.sandhya@mayo.edu
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reproduction in any medium, provided the orto initiate mammography and the frequency of screen-
ing mammography. The guidelines had last been
updated in 2002.
The USPSTF suggested that screening mammography
leads to the greatest absolute reduction in breast can-
cer mortality in women aged 50 to 74 years. The fol-
lowing were listed as potential risks from screening
mammography: psychological harm, additional medical
visits, imaging and biopsies in women without cancer,
inconvenience from false-positive screening results, and
the potential harm of unnecessary treatment and radi-
ation exposure [5-7]. The USPSTF revised guidelines
were published in the Annals of Internal Medicine in
November 2009 and recommended against routined. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Allen et al. BMC Women's Health 2012, 12:36 Page 2 of 7
http://www.biomedcentral.com/1472-6874/12/36screening mammography for women aged 40–49 years,
suggesting that routine screening mammography begin
at age 50 and continue biennially [7]. The recommen-
dation for biennial screening after age 50 was based
on modeling data that indicated biennial rather than an-
nual screening confers an improved benefit-risk ratio [8].
The announcement of these revised recommendations
created significant public controversy [9,10], and the
USPSTF, in their testimony to the Subcommittee on
Health of the House Energy and Commerce Committee
soon after the announcement, acknowledged that com-
munication about the recommendations could have been
better [11]. Subsequently, the USPSTF unanimously
voted to clarify the language in their previous statement.
On December 4, 2009, the USPSTF clarified their com-
munication and the focus was placed on the second sen-
tence which stated, “The decision to start regular,
biennial mammography screening before age 50 years
should be an individual one and should take patient con-
text into account, including the patient’s values regarding
specific benefits and harms” [5].
The revised USPSTF recommendations received the
support of organizations such as the American College
of Physicians [12] and the American Academy of Fam-
ily Physicians [13], generally based on the notion that
the revised guidelines may help decrease perceived ex-
cessive screening leading to over-diagnosis, unnecessary
treatment, and potential psychological stress. Other
organizations, such as the American College of Obste-
trics and Gynecology, American Cancer Society, Na-
tional Comprehensive Cancer Network, American
College of Radiology, and the Susan G. Komen for the
Cure, continue to recommend initiating annual screen-
ing mammography at age 40 [7,14-16]. The USPSTF
also recommended against routine screening to avoid
characterizing all women the same way and emphasized
an individualized approach for women. The importance
of informed decision making regarding screening mam-
mography has been a point of agreement between sup-
porters and critics of the revised guidelines [17,18].
The lack of available tools to aid in decision making
provides a challenge to patients and practitioners seek-
ing to make an informed decision in this context
[7,10,16,19].
The revised guidelines were also subjected to signifi-
cant media scrutiny and criticism in the weeks immedi-
ately following publication of the guidelines in 2009
[9,10,20]. A recent study examining media content and
patient knowledge about the revised recommendations
demonstrated that the majority of newspaper articles
and social media posts published within the first two
months of the release of the revised guidelines were un-
supportive, stating that women were confused by the
recommendations [20].The current study sought to investigate the impact of
the release of the revised 2009 USPSTF screening mam-
mogram guidelines on patient understanding of the
recommended age and frequency of screening mammog-
raphy. The study also aimed to examine the patients’
plans related to decision making about future mammog-
raphy for breast cancer screening.
Methods
Study population
The study was conducted in a subset of female patients re-
ceiving continuity care within the Departments of Family
Medicine, Internal Medicine, and Obstetrics & Gynecology
at a tertiary care medical center between March 25, 2010
and May 31, 2010. Female patients (n = 304) between the
ages of 40 and 75, who were due for health maintenance or
gynecologic examination during the two-month period,
were selected at random through computerized selection.
Selected patients were mailed a letter and survey inviting
their participation in the study. Patients who did not res-
pond to the first mailing received a second mailing. Those
who did not return a completed survey after the second
mailing were classified as nonresponders. The Mayo Clinic
Institutional Review Board approved the study prior to
recruitment.
Measures
Through careful consideration by the authors and input
from the Mayo Clinic Institutional Review Board and
survey specialists, a survey was created to assess the im-
pact of the release of the revised 2009 USPSTF screening
mammogram guidelines. The survey focused on patient
awareness, interpretation, feelings (measured on a Likert
scale), and future plans regarding screening mammog-
raphy. Topics of interest included (see Additional file 1):
 Demographics, screening mammography status, and
family history
 Understanding of the guidelines and how they
received information about the revised screening
mammogram guidelines
 Understanding of screening recommendations
 Impact of revised screening mammogram guidelines
on feelings related to screening and personal health
status (health anxiety)
 State anxiety
 Personal and family history related to breast cancer,
and awareness of institutional position on the
revised guidelines
Statistical analyses
Our primary goal was to describe the distribution of the
responses of a patient population to the survey ques-
tions. Categorical survey responses were summarized
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and age was summarized with use of mean and range.
A secondary goal was to examine potential differences
among the women invited to participate in the study.
Responses were compared between demographic charac-
teristics using the Fisher exact test. Respondents were
compared to nonrespondents with respect to age (2-sample
t-test) and county residency (chi-square test) to see whether
there may have been response bias with respect to these
characteristics. Comparisons yielding p-values less than
0.05 were considered statistically significant. All analyses




Of the 304 patients who were sent a survey, 150 patients
(approximately 50%) responded. Responders and nonre-
sponders did not differ significantly between age and
residence. Among the 150 responders, the majority were
white (96%), mean age 56 years (range 40–75), and were
in the age group of 50 to 75 years old (n = 91). Most of
the patients (61%) reported living in counties adjacent to
the medical center and only 13% reported living outside
of the state. All (100%) surveyed participants had com-
pleted high school; 25% had completed college and 12%
had a graduate degree. Most patients (97%) reported
currently receiving annual screening mammograms and
49% reported having had more than 10 previous
mammograms.
Awareness of the revised 2009 USPSTF guidelines
Of the respondents, 62% were somewhat aware and 25%
were very aware of the revised USPSTF guidelines; only
13% reported being unaware of the revised guidelines.
The majority of patients (92%) reported that they had
learned about the guidelines through the news media
and the remaining participants learned through internet
(16%), health care provider (12%), family and friends
(11%), books and magazine (7%), and other sources
(3%). Patients (54%) also indicated they were unaware of
their medical institution’s position on the new USPSTF
guidelines.
Understanding of the revised guidelines
In general, a majority of the patients understood and
were in agreement with the general breast cancer screen-
ing recommendations in place before the release of the
revised USPSTF guidelines (Table 1). Understanding was
less apparent among participants after the release of the
revised guidelines (Table 1). Most participants reported
not being confident (46%) or somewhat confident (41%)
about their understanding of the revised guidelines.Emotions related to revised guidelines
A majority of patients (66.7%) reported being more con-
fused following the release of the revised guidelines
(Table 2). Additionally, while most patients reported no
or minimal state anxiety (i.e., current general anxiety at
the time of survey completion), a number of the patients
reported feeling more anxious as a result of the revised
screening guidelines. Greater than 50% of the patients
also reported more anxiety about their health status fol-
lowing the revised guidelines (Table 2).
Family history of breast cancer
Among the 150 responding patients, 57 (38%) reported a
family history of breast cancer (of the 38%: 40% reported
mother, 19% reported sister, 2% reported daughter, and
63% reported other); 62% of the patients had no such
family history. There was no significant difference in the
lifetime number of mammograms between women with
and without a family history of breast cancer. More
patients with a family history of breast cancer than those
without (35% vs. 18%) reported being very aware of the
revised screening guidelines (p < .05). There were, how-
ever, no significant differences in these groups with
regards to state anxiety about screening mammograms
or health status following the release of the revised
USPSTF guidelines.
Decision regarding future plans for screening
mammograms
Of the responding patients, 75% did not expect to
change the age at initiation or frequency of screening
mammography in the future, whereas 25% either
expected to change or did not know if they would alter
their screening behavior (Table 3). Between these
groups, there was a significant difference in the under-
standing of how frequently it is now recommended that
women have screening mammograms between 40 and
50 years of age (p = .02). Uncertainty of the revised
guidelines was greater among women planning to
change their screening practices versus those who were
not planning to change (54% vs. 25%). There was also a
significant difference between these groups on reported
anxiety related to screening mammograms (p = .03),
with patients expecting to change their practice (or un-
certain of whether to do so) reporting significantly more
anxiety (54% vs. 27%). No significant difference was
found between these groups with respect to anxiety
regarding their health status.
Discussion
Preventive care is an important component of health
care. New or revisions to preventive care guidelines, es-
pecially when controversial, present immense challenges
to patients as well as providers as they influence the
Table 1 Patient understanding of screening recommendations before and after the release of the revised guidelines
n* (%, 95% Confidence Interval)
Survey question Before release After release
What was your understanding regarding the age at which most women should begin screening mammograms?
Under 40 years old 23 (15.3, 10.4-22.0) 7 (4.7, 2.3-9.4)
40 to 49 years old 118 (78.7, 71.4-84.5) 22 (14.9, 10.0-21.5)
50 to 60 years old 5 (3.3, 1.4-7.6) 85 (57.4, 49.4-65.1)
Over 60 years old 1 (0.7, 0.1-3.7) 5 (3.4, 1.5-7.7)
Not sure 3 (2.0, 0.7-5.7) 29 (19.6, 14.0-26.7)
What was your understanding of how frequently it is recommended that women have screening mammograms between 40 and 50 years of age?
No screening 0 43 (28.9, 22.2-36.6)
Yearly 119 (79.3, 72.2-85.0) 11 (7.4, 4.2-12.7)
Every other year 17 (11.3, 7.2-17.4) 26 (17.4, 12.2-24.3)
Every three years or more 8 (5.3, 2.7-10.2) 19 (12.8, 8.3-19.1)
Not sure 6 (4.0, 1.8-8.5) 50 (33.6, 26.5-41.5)
What was your understanding of how frequently it is recommended that women have screening mammograms 51 years and older?
No screening 1 (0.7, 0.1-3.7) 2 (1.3, 0.4-4.8)
Yearly 126 (84.0, 77.3-89.0) 26 (17.4, 12.2-24.3)
Every other year 8 (5.3, 2.7-10.2) 40 (26.8, 20.4-34.5)
Every three years or more 4 (2.7, 1.0-6.7) 21 (14.1, 9.4-20.6)
Not sure 11 (7.3, 4.1-12.7) 60 (40.3, 32.7-48.3)
*Totals not adding to 150 indicate missing data (not included in percentage calculation).
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process. In this study, we found that most of the patients
learned of the revised guidelines through the media. A
majority of the women in the survey study reported they
were confused and anxious after the release of the
revised guidelines and unsure about how the changes
would impact their current screening schedule.
Despite reporting awareness of the revised guidelines,
a large number of patients described low confidence in
their understanding of the revised guidelines. In
addition, more patients were in agreement with existing
recommendations about screening mammography be-
fore the release of the revised guidelines than after the
release. A large number of responders also described
increased confusion following the release of the revised
guidelines likely secondary to the change in recommen-
dations, as well as news presentations and publicized
disagreements among major health organizations [20].
As noted in the commentary by Woolf in JAMA, unless
guideline-related challenges are resolved, there will be a
lack of understanding and confusion about how and
when to pursue clinical preventive services [9].
In addition to reported confusion regarding the age
at which to initiate mammography as well as the fre-
quency of screening, many of the patients also
described feeling more anxious about mammography
screening and about their own health status as a result
of the change in screening guidelines. This is striking,particularly because a majority of the participating patients
(80%) reported very little or no anxiety (i.e., state anxiety)
at the time of the survey completion. These findings
emphasize the need for improved communication of the
role of screening mammography and its impact on a
woman’s health.
A majority of the patients in the current study did
not expect to change their age of initiation of mam-
mography and frequency of screening despite the
revised guidelines. Patients expecting to change their
screening practice did, however, report significantly
more anxiety about screening mammograms than their
counterparts. It is generally expected that a family his-
tory of breast cancer will impact the willingness of
patients to engage in frequent screening. In the current
study, patients with a family history of breast cancer
reported higher awareness of the new screening guide-
lines. There were, however, no significant differences
between these groups with regard to frequency or
number of previous mammograms, nor any significant
differences with regard to current state anxiety about
screening mammograms, or anxiety about health sta-
tus following the release of the revised USPSTF
guidelines. It is possible that patients with a family
history of breast cancer have a greater knowledge and
understanding of the role of screening mammograms
although they too could benefit from shared decision-
making tools.
Table 2 Impact of new screening guidelines on patients: confusion and anxiety
Survey question n* (%, 95% Confidence Interval)
The new USPSTF screening guidelines/recommendations have made me feel:
Less confused about screening mammograms 4 (2.7, 1.1-6.8)
No change about screening mammograms 45 (30.6, 23.7-38.5)
More confused about screening mammograms 71 (48.3, 40.4-56.3)
Much more confused about screening mammograms 27 (18.4, 12.9-25.4)
Please note how anxious you feel at the moment (“state anxiety”).
Not at all anxious 84 (56.8, 48.7-64.5)
A little anxious 35 (23.6, 17.5-31.1)
Moderately anxious 15 (10.1, 6.2-16.0)
Very anxious 12 (8.1, 4.7-13.6)
Extremely anxious 2 (1.4, 0.4-4.8)
The new USPSTF screening guidelines/recommendations have





Much less anxious 2 (1.4, 0.4-4.8) 2 (1.4, 0.4-4.9)
Less anxious 4 (2.7, 1.1-6.7) 2 (1.4, 0.4-4.9)
No change 81 (54.7, 46.7-62.5) 84 (57.5, 49.4-65.3)
More anxious 50 (33.8, 26.7-41.7) 46 (31.5, 24.5-39.4)
Much more anxious 11 (7.4, 4.2-12.8) 12 (8.2, 4.8-13.8)
Abbreviation: USPSTF, United States Preventive Services Task Force.
*Totals not adding to 150 indicate missing data (not included in percentage calculation).
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fusion, anxiety, and lack of confidence in the current
screening guidelines since the release of the revised
USPSTF screening mammogram. Although causality for
these findings can be multifactorial, it is not clearly
known whether it was the revised USPSTF guidelines or
the media portrayal of the guidelines that contributed to
the increasing confusion. Other factors contributing to
patient confusion may have been the variable opinions
of clinicians when communicating the issue of the
revised guidelines, as well as the short time interval be-
tween the release of the new recommendations and this
study.Table 3 Patient intent to change practice
Survey question n* (%, 95%
Confidence Interval)
As a result of the new USPSTF
screening guidelines/recommendations,
are you expecting to change the time
and/or frequency of when you
receive your screening
mammograms in the future?
No 111 (75.0, 67.5-81.3)
Yes 7 (4.7, 2.3-9.4)
Not sure 30 (20.3, 14.6-27.5)
Abbreviation: USPSTF, United States Preventive Services Task Force.
*2 missing responses among patients (not included in calculations of
percentages).The confusion and anxiety reported by the patients in
the current study highlight a pronounced need to im-
prove the communication and presentation of informa-
tion to patients. The revised guidelines emphasize the
importance of individual risk assessment and desirability
of shared decision making with patients, particularly
with regards to mammogram screening for women 40–49
years of age. Organizations that create or change guide-
lines may consider simultaneously creating decision-
making tools, which can be used to communicate
appropriate and relevant information to improve patient
understanding of guidelines, that address the issues at
hand and individual needs of the patient. Decision aids
used in patient education have been shown to be effect-
ive and to improve patient understanding of options
and potential outcomes, and there is research available
providing suggestions for guidelines and quality criteria
frameworks for the development and use of patient de-
cision aids [22]. For example, in Australia and Canada,
mammography screening decision aids have already
been created, and in Australia the new shared decision-
making tool is currently undergoing a clinical trial
[23,24].
Necessary for shared decision making is understanding
personal risk, and unfortunately, conveying the concept
of risk to a patient is often challenging [25]. Decision-
making tools could help to reduce anxiety by providing
a concise review of the risks, benefits, and limitations of
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options [26].
The current study aimed to capture the perceived im-
pact of the release of the revised USPSTF screening
mammography guidelines for a subgroup of patients
shortly after the information about the new guidelines
were provided to the public. Because existing validated
surveys reflecting issues raised by the revised USPSTF
screening mammogram guidelines were not available, a
new survey was designed to address the specific aims of
this study. The survey post-test design makes it difficult
to determine causality of the results. However, the sur-
vey questions specifically focused on impact (e.g., “The
new USPSTF screening guidelines have made me
feel. . .”) and clearly relates to this issue. Participants in
this study were primarily white and associated with a
single medical center that supported annual screening
mammograms beginning age 40. These factors could po-
tentially influence generalizability of our findings. In
addition, local and national media reports on the topic
may have introduced bias. However, the patients in this
study did not receive a direct mailing from their health
care providers related to breast cancer screening, and
even though a majority of the participants reported
learning about the new guidelines through the media,
most responders denied being aware of the institution’s
position on the revised guidelines. The results from this
study may possibly represent the general public’s under-
standing and impact of the release and presentation of
the revised guidelines.
Conclusions
This study demonstrated that since the release of the
revised USPSTF screening mammogram guidelines,
women have experienced confusion, anxiety, and lack of
confidence in the current screening guidelines. It is not
clearly known whether it was the revised USPSTF guide-
lines or the media portrayal of the guidelines that con-
tributed to the increased confusion. Even when based on
the same evidence, cancer screening guidelines can differ
among different organizations and can create confusion
among the public, health care providers, and policy
makers. Findings from this study emphasize the import-
ance of a systematic approach to the development of
screening guidelines and communication to the public in
particular, as the choices regarding cancer screening in-
volve more complex psychological, scientific, and finan-
cial factors [27]. Prudence would dictate that in order to
make informed decisions, patients should receive infor-
mation describing risks, harms, and benefits of screen-
ing. The development of shared decision-making tools,
as well as appropriate endpoints or outcomes of such
tools, should be considered to address communication
challenges that may arise from the release of newguidelines. These tools should be individualized to aid
women when counseling and educating them about the
utilization of screening mammograms.
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